TARS NASDAQ
Tarsus Pharmaceuticals, Inc.
1W: -3.5%
1M: -11.8%
3M: +8.9%
YTD: -9.6%
1Y: +27.3%
3Y: +362.3%
5Y: +220.5%
$73.00
-2.46 (-3.26%)
Weekly Expected Move ±7.1%
$63
$68
$73
$78
$83
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$606M
Revenue
+105.2% YoY
$-46M
Net Income
+49.5% YoY
$62M
Free Cash Flow
+170.1% YoY
93.0%
Gross Margin
-11.4%
Op. Margin
-10.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-13.7%
ROA-8.4%
ROIC268.1%
Valuation
P/E-67.0
P/B9.1
EV/EBITDA-67.3
Leverage
Debt/Equity0.26
Current Ratio3.20
Interest Cov.-5.8x
Quality Scores
Piotroski F5/9
Altman Z6.71
Beneish M-2.82